Literature DB >> 15691523

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

Aurelija Jucaite1, Elisabeth Fernell, Christer Halldin, Hans Forssberg, Lars Farde.   

Abstract

BACKGROUND: The hypothesis that altered dopamine transmission underlies hyperactive-inattentive behavior in children with attention-deficit/hyperactivity disorder (ADHD) is based on genetic studies and the efficacy of psychostimulants. Most of previous positron emission tomography (PET) and single photon emission tomography (SPET) studies have shown altered binding of dopamine markers in the basal ganglia. Yet, the functional role of the neurochemical disturbances are poorly understood. The purpose of our study was to examine dopamine transporter (DAT) and dopamine D2 receptor (D2R) binding in adolescents with ADHD and to search for its relationship with cognitive functions as well as locomotor hyperactivity.
METHODS: Twelve adolescents with ADHD and 10 young adults were examined with PET using the selective radioligands [11C]PE2I and [11C]raclopride, indexing DAT and D2R density. The simplified reference tissue model was used to calculate binding potential (BP) values. Attention and motor behavior were investigated with a continuous performance task (CPT) and motion measurements.
RESULTS: The BP value for [11C]PE2I and [11C]raclopride in the striatum of children with ADHD did not differ from that of the young adult control subjects. In the midbrain, however, the BP values for DAT were significantly lower (16%; p = .03) in children with ADHD. Dopamine D2 receptor binding in the right caudate nucleus correlated significantly with increased motor activity (r = .70, p = .01).
CONCLUSIONS: The lower BP values for DAT in the midbrain suggest that dopamine signaling in subjects with ADHD is altered. Altered dopamine signaling might have a causal relationship to motor hyperactivity and might be considered as a potential endophenotype of ADHD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691523     DOI: 10.1016/j.biopsych.2004.11.009

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  64 in total

1.  Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.

Authors:  Kafui Dzirasa; H Westley Phillips; Tatyana D Sotnikova; Ali Salahpour; Sunil Kumar; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

Review 3.  Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view.

Authors:  Marc Schneider; Wolfgang Retz; Andrew Coogan; Johannes Thome; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

4.  Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I.

Authors:  H Umesha Shetty; Sami S Zoghbi; Jeih-San Liow; Masanori Ichise; Jinsoo Hong; John L Musachio; Christer Halldin; Jurgen Seidel; Robert B Innis; Victor W Pike
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-10       Impact factor: 9.236

5.  DAT1 Gene Methylation as an Epigenetic Biomarker in Attention Deficit Hyperactivity Disorder: A Commentary.

Authors:  Erika Tonelli; Esterina Pascale; Miriam Troianiello; Claudio D'Addario; Walter Adriani
Journal:  Front Genet       Date:  2020-05-11       Impact factor: 4.599

6.  Methylphenidate and Guanfacine Ameliorate ADHD-Like Phenotypes in Fez1-Deficient Mice.

Authors:  Akiko Sumitomo; Ayumi Saka; Keisho Ueta; Kouta Horike; Kazuko Hirai; Nao J Gamo; Takatoshi Hikida; Keiichi I Nakayama; Akira Sawa; Takeshi Sakurai; Toshifumi Tomoda
Journal:  Mol Neuropsychiatry       Date:  2018-04-26

Review 7.  Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.

Authors:  Eduardo F Gallo
Journal:  Neurochem Int       Date:  2019-02-01       Impact factor: 3.921

8.  Intracortical motor inhibition and facilitation in adults with attention deficit/hyperactivity disorder.

Authors:  Jacqueline Hoeppner; Martin Neumeyer; Roland Wandschneider; Sabine C Herpertz; Wolfgang Gierow; Frank Haessler; Johannes Buchmann
Journal:  J Neural Transm (Vienna)       Date:  2008-11-06       Impact factor: 3.575

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

10.  Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleep.

Authors:  Kafui Dzirasa; Lucas M Santos; Sidarta Ribeiro; Jennifer Stapleton; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.